Open AccessImmune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review)
Author(s) -
К. V. Menshikov,
А. V. Sultanbaev,
Ш. И. Мусин,
А. А. Измайлов,
Oleg Lipatov,
I. A. Menshikovа,
Н. И. Султанбаева,
E. V. Popova
Publication year - 2022
Publication title -
kreativnaâ hirurgiâ i onkologiâ
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2307-0501
pISSN - 2076-3093
DOI - 10.24060/2076-3093-2022-12-3-205-216
Subject(s) - durvalumab , medicine , atezolizumab , avelumab , metastatic urothelial carcinoma , nivolumab , bladder cancer , pembrolizumab , oncology , immune checkpoint , cisplatin , cancer , chemotherapy , immunotherapy , urothelial carcinoma